InsiderTrades

Form 4 for MRNA Moderna

Accepted 2021-08-13 00:00:00 ET · period of report 2021-08-11 · accession 0001127602-21-023649 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
I 2021-08-13 2021-08-12 MRNA Bancel Stephane CEO, Dir S - Sale $400.00 -10.0K 7.28M -0.1% -$4.00M
2021-08-13 2021-08-11 MRNA Bancel Stephane CEO, Dir G - Gift — -4,000 6.16M -0.1% —
2021-08-13 2021-08-11 MRNA Bancel Stephane CEO, Dir S - Sale $443.34 -9,000 6.17M -0.1% -$3.99M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-08-12 S D 10,000 $400.00 7,284,880 I — —
2 Common Common Stock 2021-08-11 G D 4,000 — 6,161,868 D — — (F3) The reported disposition represents a bona fide charitable gift made by the reporting person.
3 Common Common Stock 2021-08-11 S D 9,000 $443.34 6,165,868 D See Footnote — — (F5) These shares are owned directly by OCHA LLC ("OCHA"). The reporting person is the majority equity unit holder and the sole managing member of OCHA. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.